Sign In

Maura L. Gillison MD, PhD

Maura L. Gillison MD, PhD
ProfessorCollege of MedicineMaura.Gillison@osumc.edu
690 Tzagournis Research Facility 420 W 10th Avenue Columbus OH 43210
Phone:614-247-4589Fax: 614-688-4245
  • Cancer Control
  • Viral Oncology

General Research Interest

Head and neck cancer, human papillomavirus, infectious-disease tumor associations

Research Description

The principal focus of the Gillison laboratory is to investigate the role of human papillomavirus infection in head and neck malignancies, from cohort studies of oral HPV infection to genetic indicators of response to chemoradiotherapy.

Transinstitutional Work

The Gillison laboratory has several ongoing collaborations with the Centers for Disease Control, USA, the National Cancer Institute, USA, and the International Agency for Research on Cancer. Dr. Gillison is also a member of the head and neck steering committees of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group.

Current Publications

  • Beachler DC, D'Souza G, Sugar EA, Xiao W, Gillison MLNatural History of Anal vs Oral HPV Infection in HIV-Infected Men and Women.J Infect Dis in press 5/13/2013
  • Gillison ML, Castellsagué X, Chaturvedi A, Goodman MT, Snijders P, Tommasino M, Arbyn M, Franceschi SComparative epidemiology of HPV infection and associated cancers of the head and neck and cervix.Int J Cancer in press 4/9/2013
  • Lingen MW, Xiao W, Schmidt A, Jiang B, Pickard R, Kreinbrink P, Perez-Ordonez B, Jordan RC, Gillison MLLow etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas.Oral Oncol 49(1) 1-8 1/1/2013
  • Gillison ML, Alemany L, Snijders PJ, Chaturvedi A, Steinberg BM, Schwartz S, Castellsagué XHuman papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis.Vaccine 30 Suppl 5 F34-54 11/20/2012
  • Perez-Ordoñez B, Irish JC, Yu ES, Gillison MLHuman Papillomavirus-16 Associated Adenocarcinoma NOS of Base of Tongue.Head Neck Pathol in press 10/10/2012
  • Hoskins EE, Morreale RJ, Werner SP, Higginbotham JM, Laimins LA, Lambert PF, Brown DR, Gillison ML, Nuovo GJ, Witte DP, Kim MO, Davies SM, Mehta PA, Kovacic MB, Wikenheiser-Brokamp KA, Wells SIThe fanconi anemia pathway limits human papillomavirus replication.J Virol 86(15) 8131-8 8/1/2012
  • Pickard RK, Xiao W, Broutian TR, He X, Gillison MLThe prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years.Sex Transm Dis 39(7) 559-66 7/1/2012
  • Jordan RC, Lingen MW, Perez-Ordonez B, He X, Pickard R, Koluder M, Jiang B, Wakely P, Xiao W, Gillison MLValidation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.Am J Surg Pathol 36(7) 945-54 7/1/2012
  • Gillison ML, Zhang Q, Jordan R, Xiao W, Westra WH, Trotti A, Spencer S, Harris J, Chung CH, Ang KKTobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer.J Clin Oncol 30(17) 2102-11 6/10/2012
  • Gilbert J, Rudek MA, Higgins MJ, Zhao M, Bienvenu S, Tsottles N, Wahl RL, Forastiere AA, Gillison MLA phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck.Clin Cancer Res 18(6) 1735-42 3/15/2012
  • Pfister DG, Ang KK, Brizel DM, Burtness B, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Sanguineti G, Schuller DE, Shah JP, Spencer S, Trotti A 3rd, Weber RS, Wolf G, Worden FMucosal melanoma of the head and neck.J Natl Compr Canc Netw 10(3) 320-38 3/1/2012
  • Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, Graubard BI, Chaturvedi AKPrevalence of oral HPV infection in the United States, 2009-2010.JAMA 307(7) 693-703 2/15/2012
  • Beachler DC, Weber KM, Margolick JB, Strickler HD, Cranston RD, Burk RD, Wiley DJ, Minkoff H, Reddy S, Stammer EE, Gillison ML, D'Souza GRisk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults.Cancer Epidemiol Biomarkers Prev 21(1) 122-33 1/1/2012
  • Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison MLHuman papillomavirus and rising oropharyngeal cancer incidence in the United States.J Clin Oncol 29(32) 4294-301 11/10/2011
  • Fakhry C, Rosenthal B, Clark DP, Gillison MLAssociations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations.Cancer Prev Res (Phila) 4(9) 1378-84 9/1/2011